8 documents found, page 1 of 1
Asdas responses in patients with axial spondyloarthritis starting bdmards: resu...
Santos, M. E.; Ramiro, S.; Van der Heijde, D.; Landewé, R.; Santos, F. Pimentel; Machado, A. R. Cruz; Ferreira, C.; Gomes, C.; Soares, C. DantasASAS and EULAR recommend the use of an improvement ≥1.1 in ASDAS at 12 weeks to determine the continuation of a bDMARD. However, it is debated whether improvements can occur and whether patients’ characteristics influence (time to) response.
Portuguese recommendations for the management of Raynaud’s phenomenon and digit...
Santiago, T.; Duarte, A. C.; Sepriano, A.; Castro, A.; Rosa, B.; Resende, C.; Oliveira, D.; Dourado, D.; Costa, E.; Santos, F. Cunha; Terroso, G.Objective: To develop evidence-based recommendations for the non-pharmacological and pharmacological management of Raynaud's phenomenon (RP) and digital ulcers (DUs) in patients with systemic sclerosis and other immune-mediated connective tissue diseases (CTDs). Methods: A task force comprising 21 rheumatologists, 2 surgeons (vascular and plastic), 2 nurses, and 1 patient representative was established. Followi...
Prevalence and clinical characteristics of late Onset Axial Spondyloarthritis: ...
Rocha, Margarida Lucas; Torres, R.; Ramiro, S.; Castro, A. M.; Neves, A.; Martins, A.; Chícharo, A. T.; Mendes, B.; Matos, C. O.; Soares, C.Axial spondyloarthritis (axSpA) typically starts before the fourth decade oflife. Consistent with that, the Assessment of SpondyloArthritis international Society (ASAS)classification criteria for axSpA should be applied only in patients with chronic back pain startingbefore 45 years of age. It has, however, been suggested that axSpA can sometimes start later in lifewith a distinctive phenotype, the so-called ‘l...
Portuguese Recommendations for the use of biological therapies in patients with...
Duarte, C.; Sousa-Neves, J.; Águeda, A.; Ribeiro, P.; Daniel, A.; Eugénio, G.; Serra, S.; Araújo, F.; Barcelos, A.; Filipe, B.; Bernardes, M.
The Portuguese Society of Rheumatology position paper on the use of biosimilars...
Araújo, F. C.; Sepriano, A.; Teixeira, F.; Jesus, D.; Rocha, T. M.; Martins, P.; Tenazinha, C.; Cordeiro, A.; Mourão, A. F.; Silva, C.; Vaz, C.
Portuguese recommendations for the use of biological therapies in patients with...
Machado, P. M.; Cerqueira, M.; Ávila-Ribeiro, P.; Aguiar, R.; Bernardo, A.; Sepriano, A.; Águeda, A.; Cordeiro, A.; Raposo, A.; Rodrigues, A. M.
Portuguese recommendations for the use of methotrexate in rheumatic diseases – ...
Duarte, A. C.; Santos-Faria, D.; Gonçalves, M. J.; Sepriano, A.; Mourão, A. F.; Duarte, C.; Neves, J. S.; Águeda, A. F.; Ribeiro, P. A.; Daniel, A.
Asas health index for patients with spondyloarthritis: translation into portugu...
Rodrigues Manica, S.; Cruz, Eduardo Brazete; Ramiro, S.; Sousa, S.; Aguiar, R.; Sepriano, A.; Machado, P.M.; Kiltz, U.; Branco, J.C.